Outcomes of Left Ventricular Assist Device for Patients with Hypertrophic Cardiomyopathy

The treatment of end stage hypertrophic cardiomyopathy (HCM) is sometimes complicated because some cases of HCM are not suitable for LVAD. Scarce data exist on outcomes of continuous-flow (CF) LVAD support in these challenging patient cohorts. We evaluated the clinical outcomes of LVAD therapy for patients with HCM.

Source: The Journal of Heart and Lung Transplantation - March 31, 2020 Category: Transplant Surgery Authors: K. Suzuki, D. Yoshioka, K. Toda, S. Miyagawa, Y. Yoshikawa, H. Hata, S. Kainuma, T. Kawamura, A. Kawamura, T. Samura, Y. Sawa Tags: (361) Source Type: research